Madison Avenue Partners crosses 5% voting rights threshold in Lakefront Biotherapeutics

Regulation
โดย Yahoo Finance·Read original
Summary · why it matters

Lakefront Biotherapeutics received a transparency notification from Madison Avenue Partners indicating that the investment firm crossed above the 5% voting rights threshold on an aggregated basis on June 15, 2026. Following the acquisition of voting rights, Madison Avenue Partners, jointly with its affiliates, held 3,498,892 voting rights as of June 24, 2026, representing 5.31% of Lakefront's currently outstanding 65,897,071 shares. The notification was made pursuant to Belgian transparency legislation.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks

Off-coverage companies 1

Madison Avenue PartnersPrivate▲ Positive
Capitalrelevance

The firm increased its stake in Lakefront Biotherapeutics, but the news is about its investment activity, not its own operations.

© 2026 MarketDXNews